Copyright Reports & Markets. All rights reserved.

Global Imatinib Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Imatinib Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Imatinib Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Imatinib Drugs Market Size Growth Rate by Type
    • 1.4.2 Capsules
    • 1.4.3 Tablets
  • 1.5 Market by Application
    • 1.5.1 Global Imatinib Drugs Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Drug Stores
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Imatinib Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Imatinib Drugs Revenue 2015-2026
    • 2.1.2 Global Imatinib Drugs Sales 2015-2026
  • 2.2 Global Imatinib Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Imatinib Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Imatinib Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Imatinib Drugs Competitor Landscape by Players

  • 3.1 Imatinib Drugs Sales by Manufacturers
    • 3.1.1 Imatinib Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Imatinib Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Imatinib Drugs Revenue by Manufacturers
    • 3.2.1 Imatinib Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Imatinib Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Imatinib Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2019
    • 3.2.5 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Imatinib Drugs Price by Manufacturers
  • 3.4 Imatinib Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Imatinib Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Imatinib Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Imatinib Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Imatinib Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Imatinib Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Imatinib Drugs Revenue by Type (2015-2020)
    • 4.1.3 Imatinib Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Imatinib Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Imatinib Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Imatinib Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Imatinib Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Imatinib Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Imatinib Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Imatinib Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Imatinib Drugs Revenue by Application (2015-2020)
    • 5.1.3 Imatinib Drugs Price by Application (2015-2020)
  • 5.2 Imatinib Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Imatinib Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Imatinib Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Imatinib Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Imatinib Drugs by Country
    • 6.1.1 North America Imatinib Drugs Sales by Country
    • 6.1.2 North America Imatinib Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Imatinib Drugs Market Facts & Figures by Type
  • 6.3 North America Imatinib Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Imatinib Drugs by Country
    • 7.1.1 Europe Imatinib Drugs Sales by Country
    • 7.1.2 Europe Imatinib Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Imatinib Drugs Market Facts & Figures by Type
  • 7.3 Europe Imatinib Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Imatinib Drugs by Region
    • 8.1.1 Asia Pacific Imatinib Drugs Sales by Region
    • 8.1.2 Asia Pacific Imatinib Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Imatinib Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Imatinib Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Imatinib Drugs by Country
    • 9.1.1 Latin America Imatinib Drugs Sales by Country
    • 9.1.2 Latin America Imatinib Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Imatinib Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Imatinib Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Imatinib Drugs by Country
    • 10.1.1 Middle East and Africa Imatinib Drugs Sales by Country
    • 10.1.2 Middle East and Africa Imatinib Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Imatinib Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Imatinib Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Apotex Inc.
    • 11.1.1 Apotex Inc. Corporation Information
    • 11.1.2 Apotex Inc. Description and Business Overview
    • 11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Apotex Inc. Imatinib Drugs Products Offered
    • 11.1.5 Apotex Inc. Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Imatinib Drugs Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Sanofi S.A.
    • 11.3.1 Sanofi S.A. Corporation Information
    • 11.3.2 Sanofi S.A. Description and Business Overview
    • 11.3.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sanofi S.A. Imatinib Drugs Products Offered
    • 11.3.5 Sanofi S.A. Related Developments
  • 11.4 Cipla Inc.
    • 11.4.1 Cipla Inc. Corporation Information
    • 11.4.2 Cipla Inc. Description and Business Overview
    • 11.4.3 Cipla Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Cipla Inc. Imatinib Drugs Products Offered
    • 11.4.5 Cipla Inc. Related Developments
  • 11.5 Mylan Pharms Inc.
    • 11.5.1 Mylan Pharms Inc. Corporation Information
    • 11.5.2 Mylan Pharms Inc. Description and Business Overview
    • 11.5.3 Mylan Pharms Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Mylan Pharms Inc. Imatinib Drugs Products Offered
    • 11.5.5 Mylan Pharms Inc. Related Developments
  • 11.6 Glenmark Pharmaceuticals Ltd.
    • 11.6.1 Glenmark Pharmaceuticals Ltd. Corporation Information
    • 11.6.2 Glenmark Pharmaceuticals Ltd. Description and Business Overview
    • 11.6.3 Glenmark Pharmaceuticals Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products Offered
    • 11.6.5 Glenmark Pharmaceuticals Ltd. Related Developments
  • 11.7 Sun Pharmaceuticals
    • 11.7.1 Sun Pharmaceuticals Corporation Information
    • 11.7.2 Sun Pharmaceuticals Description and Business Overview
    • 11.7.3 Sun Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sun Pharmaceuticals Imatinib Drugs Products Offered
    • 11.7.5 Sun Pharmaceuticals Related Developments
  • 11.8 Actavis Generics
    • 11.8.1 Actavis Generics Corporation Information
    • 11.8.2 Actavis Generics Description and Business Overview
    • 11.8.3 Actavis Generics Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Actavis Generics Imatinib Drugs Products Offered
    • 11.8.5 Actavis Generics Related Developments
  • 11.9 Dr. Reddy's Laboratories
    • 11.9.1 Dr. Reddy's Laboratories Corporation Information
    • 11.9.2 Dr. Reddy's Laboratories Description and Business Overview
    • 11.9.3 Dr. Reddy's Laboratories Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Products Offered
    • 11.9.5 Dr. Reddy's Laboratories Related Developments
  • 11.10 Teva Pharmaceutical Industries Ltd.
    • 11.10.1 Teva Pharmaceutical Industries Ltd. Corporation Information
    • 11.10.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
    • 11.10.3 Teva Pharmaceutical Industries Ltd. Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products Offered
    • 11.10.5 Teva Pharmaceutical Industries Ltd. Related Developments
  • 11.1 Apotex Inc.
    • 11.1.1 Apotex Inc. Corporation Information
    • 11.1.2 Apotex Inc. Description and Business Overview
    • 11.1.3 Apotex Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Apotex Inc. Imatinib Drugs Products Offered
    • 11.1.5 Apotex Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Imatinib Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Imatinib Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Imatinib Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Imatinib Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Imatinib Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Imatinib Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Imatinib Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Imatinib Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Imatinib Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Imatinib Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Imatinib Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Imatinib Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Imatinib Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Imatinib Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Imatinib Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Imatinib Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Imatinib Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Imatinib Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Imatinib Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Imatinib Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Imatinib Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Imatinib Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Imatinib Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Imatinib Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Imatinib Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Imatinib Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Imatinib Drugs market is segmented into
    Capsules
    Tablets

    Segment by Application, the Imatinib Drugs market is segmented into
    Hospitals
    Drug Stores
    Other

    Regional and Country-level Analysis
    The Imatinib Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Imatinib Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Imatinib Drugs Market Share Analysis
    Imatinib Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Imatinib Drugs business, the date to enter into the Imatinib Drugs market, Imatinib Drugs product introduction, recent developments, etc.

    The major vendors covered:
    Apotex Inc.
    Novartis
    Sanofi S.A.
    Cipla Inc.
    Mylan Pharms Inc.
    Glenmark Pharmaceuticals Ltd.
    Sun Pharmaceuticals
    Actavis Generics
    Dr. Reddy's Laboratories
    Teva Pharmaceutical Industries Ltd.

    Buy now